The prostate cancer conundrum
While screening is an imperfect science, there is public and political pressure to take action now
By
Healthcare
The latest insights on health and social care policy, the NHS and the life sciences
Latest in
Healthcare
The oncology postcode lottery
Quality of care is often defined by where a patient lives. Fixing that is central to the National Cancer Plan,…
By
What will be the ultimate test of the National Cancer Plan’s success?
Experts from across the sector give their views.
By
The rarest of legislative wins
A private members’ bill gaining royal assent could make a huge difference to how rare cancers are treated.
By
Can the NHS reinvent itself fast enough to satisfy the National Cancer Plan?
As ever, success of the government’s National Cancer Plan will lie in the detail of delivery.
By
Spotlight on Cancer and Oncology
Commentary and analysis from Dame Laura Lee, Navendu Mishra MP, Sarah Woolnough, Kristian Helin, and more.
ByPartner content
A special supplement, sponsored by LifeArc, looking at how Britain can make progress in the battle against rare diseases.
Partner content
Clinical leadership can drive better rare disease care
Appointing a dedicated clinical leader for rare diseases could be the game-changer patients urgently need.
By